Normal view
-
cs.AI, q-bio.NC updates on arXiv.org
-
The Evaluation Gap in Medicine, AI and LLMs: Navigating Elusive Ground Truth & Uncertainty via a Probabilistic Paradigm
arXiv:2601.05500v1 Announce Type: new Abstract: Benchmarking the relative capabilities of AI systems, including Large Language Models (LLMs) and Vision Models, typically ignores the impact of uncertainty in the underlying ground truth answers from experts. This ambiguity is particularly consequential in medicine where uncertainty is pervasive. In this paper, we introduce a probabilistic paradigm to theoretically explain how high certainty in ground truth answers is almost always necessary for e
-
cs.AI, q-bio.NC updates on arXiv.org
-
A Survey of Agentic AI and Cybersecurity: Challenges, Opportunities and Use-case Prototypes
arXiv:2601.05293v1 Announce Type: cross Abstract: Agentic AI marks an important transition from single-step generative models to systems capable of reasoning, planning, acting, and adapting over long-lasting tasks. By integrating memory, tool use, and iterative decision cycles, these systems enable continuous, autonomous workflows in real-world environments. This survey examines the implications of agentic AI for cybersecurity. On the defensive side, agentic capabilities enable continuous monit
A Survey of Agentic AI and Cybersecurity: Challenges, Opportunities and Use-case Prototypes
-
MRD
-
Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making
Cancers (Basel). 2025 Dec 27;18(1):94. doi: 10.3390/cancers18010094.ABSTRACTPancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with poor long-term survival despite advances in surgical techniques, systemic therapies, and perioperative management. High rates of systemic recurrence following curative-intent resection suggest that many patients harbor minimal residual disease (MRD), microscopic tumor burden that persists postoperatively and remains undetectable by conventiona
Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making
Cancers (Basel). 2025 Dec 27;18(1):94. doi: 10.3390/cancers18010094.
ABSTRACT
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with poor long-term survival despite advances in surgical techniques, systemic therapies, and perioperative management. High rates of systemic recurrence following curative-intent resection suggest that many patients harbor minimal residual disease (MRD), microscopic tumor burden that persists postoperatively and remains undetectable by conventional diagnostic tools. Recent advances in liquid biopsy technologies, particularly circulating tumor DNA (ctDNA) analysis, alongside detailed characterization of the PDAC mutational landscape, offer a promising non-invasive approach for MRD detection. Emerging evidence indicates that MRD status can serve as a sensitive prognostic biomarker, identify patients at high risk of relapse, and guide personalized perioperative therapy, including optimization of adjuvant treatment. This review summarizes current knowledge on the biology and detection of MRD in PDAC, its implications for perioperative risk stratification and treatment decision-making, and discusses future directions for integrating MRD assessment into clinical practice to enable more precise, individualized patient management.
PMID:41514607 | PMC:PMC12784771 | DOI:10.3390/cancers18010094
-
Nature Medicine
-
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial
Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04170-zAnalysis of a placebo-controlled trial of a BCMA-targeting CAR-T cell therapy in patients with myasthenia gravis shows that CAR-T cell infusion selectively remodels the systemic immune environment, with elimination of BCMA-high plasma cells and activated plasmacytoid dendritic cells and changes in the autoreactive B cell repertoire.
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial
Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04170-z
Analysis of a placebo-controlled trial of a BCMA-targeting CAR-T cell therapy in patients with myasthenia gravis shows that CAR-T cell infusion selectively remodels the systemic immune environment, with elimination of BCMA-high plasma cells and activated plasmacytoid dendritic cells and changes in the autoreactive B cell repertoire.-
Nature Medicine
-
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial
Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04171-yIn a randomized, double-blind, placebo-controlled trial comparing autologous mRNA-engineered BCMA-targeting CAR T cell therapy versus placebo in patients with generalized myasthenia gravis, a significantly higher percentage of patients exhibited a reduction in disease activity in the treatment arm than in the placebo arm.
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial
Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04171-y
In a randomized, double-blind, placebo-controlled trial comparing autologous mRNA-engineered BCMA-targeting CAR T cell therapy versus placebo in patients with generalized myasthenia gravis, a significantly higher percentage of patients exhibited a reduction in disease activity in the treatment arm than in the placebo arm.-
cs.AI, q-bio.NC updates on arXiv.org
-
Sci-Reasoning: A Dataset Decoding AI Innovation Patterns
arXiv:2601.04577v1 Announce Type: new Abstract: While AI innovation accelerates rapidly, the intellectual process behind breakthroughs -- how researchers identify gaps, synthesize prior work, and generate insights -- remains poorly understood. The lack of structured data on scientific reasoning hinders systematic analysis and development of AI research agents. We introduce Sci-Reasoning, the first dataset capturing the intellectual synthesis behind high-quality AI research. Using community-vali
Sci-Reasoning: A Dataset Decoding AI Innovation Patterns
-
cs.AI, q-bio.NC updates on arXiv.org
-
Beyond Monolithic Architectures: A Multi-Agent Search and Knowledge Optimization Framework for Agentic Search
arXiv:2601.04703v1 Announce Type: new Abstract: Agentic search has emerged as a promising paradigm for complex information seeking by enabling Large Language Models (LLMs) to interleave reasoning with tool use. However, prevailing systems rely on monolithic agents that suffer from structural bottlenecks, including unconstrained reasoning outputs that inflate trajectories, sparse outcome-level rewards that complicate credit assignment, and stochastic search noise that destabilizes learning. To a
Beyond Monolithic Architectures: A Multi-Agent Search and Knowledge Optimization Framework for Agentic Search
-
cs.AI, q-bio.NC updates on arXiv.org
-
Balancing Usability and Compliance in AI Smart Devices: A Privacy-by-Design Audit of Google Home, Alexa, and Siri
arXiv:2601.04403v1 Announce Type: cross Abstract: This paper investigates the privacy and usability of AI-enabled smart devices commonly used by youth, focusing on Google Home Mini, Amazon Alexa, and Apple Siri. While these devices provide convenience and efficiency, they also raise privacy and transparency concerns due to their always-listening design and complex data management processes. The study proposes and applies a combined framework of Heuristic Evaluation, Personal Information Protect
Balancing Usability and Compliance in AI Smart Devices: A Privacy-by-Design Audit of Google Home, Alexa, and Siri
-
cs.AI, q-bio.NC updates on arXiv.org
-
Fast Mining and Dynamic Time-to-Event Prediction over Multi-sensor Data Streams
arXiv:2601.04741v1 Announce Type: cross Abstract: Given real-time sensor data streams obtained from machines, how can we continuously predict when a machine failure will occur? This work aims to continuously forecast the timing of future events by analyzing multi-sensor data streams. A key characteristic of real-world data streams is their dynamic nature, where the underlying patterns evolve over time. To address this, we present TimeCast, a dynamic prediction framework designed to adapt to the
Fast Mining and Dynamic Time-to-Event Prediction over Multi-sensor Data Streams
-
cs.AI, q-bio.NC updates on arXiv.org
-
Smart IoT-Based Wearable Device for Detection and Monitoring of Common Cow Diseases Using a Novel Machine Learning Technique
arXiv:2601.04761v1 Announce Type: cross Abstract: Manual observation and monitoring of individual cows for disease detection present significant challenges in large-scale farming operations, as the process is labor-intensive, time-consuming, and prone to reduced accuracy. The reliance on human observation often leads to delays in identifying symptoms, as the sheer number of animals can hinder timely attention to each cow. Consequently, the accuracy and precision of disease detection are signifi
Smart IoT-Based Wearable Device for Detection and Monitoring of Common Cow Diseases Using a Novel Machine Learning Technique
-
cs.AI, q-bio.NC updates on arXiv.org
-
Atlas 2 -- Foundation models for clinical deployment
arXiv:2601.05148v1 Announce Type: cross Abstract: Pathology foundation models substantially advanced the possibilities in computational pathology -- yet tradeoffs in terms of performance, robustness, and computational requirements remained, which limited their clinical deployment. In this report, we present Atlas 2, Atlas 2-B, and Atlas 2-S, three pathology vision foundation models which bridge these shortcomings by showing state-of-the-art performance in prediction performance, robustness, and
Atlas 2 -- Foundation models for clinical deployment
-
cs.AI, q-bio.NC updates on arXiv.org
-
A Framework for Responsible AI Systems: Building Societal Trust through Domain Definition, Trustworthy AI Design, Auditability, Accountability, and Governance
arXiv:2503.04739v2 Announce Type: replace-cross Abstract: Responsible Artificial Intelligence (RAI) addresses the ethical and regulatory challenges of deploying AI systems in high-risk scenarios. This paper proposes a comprehensive framework for the design of an RAI system (RAIS) that integrates five key dimensions: domain definition, trustworthy AI design, auditability, accountability, and governance. Unlike prior work that treats these components in isolation, our proposal emphasizes their in
A Framework for Responsible AI Systems: Building Societal Trust through Domain Definition, Trustworthy AI Design, Auditability, Accountability, and Governance
-
cs.AI, q-bio.NC updates on arXiv.org
-
SciClaims: An End-to-End Generative System for Biomedical Claim Analysis
arXiv:2503.18526v2 Announce Type: replace-cross Abstract: We present SciClaims, an interactive web-based system for end-to-end scientific claim analysis in the biomedical domain. Designed for high-stakes use cases such as systematic literature reviews and patent validation, SciClaims extracts claims from text, retrieves relevant evidence from PubMed, and verifies their veracity. The system features a user-friendly interface where users can input scientific text and view extracted claims, predic
SciClaims: An End-to-End Generative System for Biomedical Claim Analysis
-
cs.AI, q-bio.NC updates on arXiv.org
-
Multi-Modal AI for Remote Patient Monitoring in Cancer Care
arXiv:2512.00949v2 Announce Type: replace-cross Abstract: For patients undergoing systemic cancer therapy, the time between clinic visits is full of uncertainties and risks of unmonitored side effects. To bridge this gap in care, we developed and prospectively trialed a multi-modal AI framework for remote patient monitoring (RPM). This system integrates multi-modal data from the HALO-X platform, such as demographics, wearable sensors, daily surveys, and clinical events. Our observational trial
Multi-Modal AI for Remote Patient Monitoring in Cancer Care
-
Journal of Medical Internet Research
-
Developing an AI-Assisted Tool That Identifies Patients With Multimorbidity and Complex Polypharmacy to Improve the Process of Medication Reviews: Qualitative Interview and Focus Group Study
Background: Structured medication reviews (SMRs) are an essential component of medication optimization, especially for patients with multimorbidity and polypharmacy. However, the process remains challenging due to the complexities of patient data, time constraints, and the need for coordination among health care professionals (HCPs). This study explores HCPs’ perspectives on the integration of artificial intelligence (AI)–assisted tools to enhance the SMR process, with a focus on the potential b
Developing an AI-Assisted Tool That Identifies Patients With Multimorbidity and Complex Polypharmacy to Improve the Process of Medication Reviews: Qualitative Interview and Focus Group Study
-
Journal of Medical Internet Research
-
Intervention in Health Misinformation Using Large Language Models for Automated Detection, Thematic Analysis, and Inoculation: Case Study on COVID-19
Background: The rapid growth of social media as an information channel has enabled the swift spread of inaccurate or false health information, significantly impacting public health. This widespread dissemination of misinformation has caused confusion, eroded trust in health authorities, led to noncompliance with health guidelines, and encouraged risky health behaviors. Understanding the dynamics of misinformation on social media is essential for devising effective public health communication str
Intervention in Health Misinformation Using Large Language Models for Automated Detection, Thematic Analysis, and Inoculation: Case Study on COVID-19
-
STAT

-
STAT+: OpenAI invites you to upload medical records to ChatGPT
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Millions of people, including me and possibly you, are already asking ChatGPT questions about health. Still others are dumping otherwise inscrutable medical records downloaded from patient portals into the generative AI bot, hoping to glean new insights. Now, OpenAI will encourage this behavior
STAT+: OpenAI invites you to upload medical records to ChatGPT
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Millions of people, including me and possibly you, are already asking ChatGPT questions about health. Still others are dumping otherwise inscrutable medical records downloaded from patient portals into the generative AI bot, hoping to glean new insights.
Now, OpenAI will encourage this behavior with a new health specific tab in the service that the company says has better security and privacy protections so users feel safe pouring sensitive medical data into the bot. In addition to uploading files, users can hook up data from products like Apple Health and Weight Watchers or obtain medical records from providers through b.well’s network. OpenAI promises that it won’t train its models on the data you put into ChatGPT Health. (Reminder: Data that you upload to a consumer service is not covered by HIPAA.)
Continue to STAT+ to read the full story…


© Adobe
-
Journal of Medical Internet Research
-
National Institutes of Health–Funded Artificial Intelligence and Machine Learning Research, 2019‐2023: Cross-Sectional Study
Inflation-adjusted funding for ML/AI research increased by 233% between FY 2019 and 2023, outpacing the overall NIH budget increase of 12%.
National Institutes of Health–Funded Artificial Intelligence and Machine Learning Research, 2019‐2023: Cross-Sectional Study
-
Journal of Medical Internet Research
-
A Web-Based Cancer Prevention Intervention for Rural Emerging Adults: Mixed Methods Development and Pilot-Testing Study
Background: The rapid growth of user-generated web-based health information increases the complexity of cancer information seeking. One promising strategy for promoting high-quality cancer information consumption is through targeted interventions that are intentionally designed to reach individuals in the web-based spaces they occupy. However, there is a paucity of evidence-based information on the best strategies for designing and implementing web-based health behavior change interventions to i
A Web-Based Cancer Prevention Intervention for Rural Emerging Adults: Mixed Methods Development and Pilot-Testing Study
-
cs.AI, q-bio.NC updates on arXiv.org
-
A Proposed Paradigm for Imputing Missing Multi-Sensor Data in the Healthcare Domain
arXiv:2601.03565v1 Announce Type: cross Abstract: Chronic diseases such as diabetes pose significant management challenges, particularly due to the risk of complications like hypoglycemia, which require timely detection and intervention. Continuous health monitoring through wearable sensors offers a promising solution for early prediction of glycemic events. However, effective use of multisensor data is hindered by issues such as signal noise and frequent missing values. This study examines the